{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Bone and bones \u00b7 Insulin resistance \u00b7 Obesity \u00b7 Vitamin D"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": [], "OtherID": [], "GeneralNote": [], "PMID": "38886966", "DateRevised": {"Year": "2024", "Month": "06", "Day": "20"}, "Article": {"Language": ["eng"], "ELocationID": ["10.11005/jbm.2024.31.2.75"], "ArticleDate": [{"Year": "2024", "Month": "05", "Day": "31"}], "Journal": {"ISSN": "2287-6375", "JournalIssue": {"Volume": "31", "Issue": "2", "PubDate": {"Year": "2024", "Month": "May"}}, "Title": "Journal of bone metabolism", "ISOAbbreviation": "J Bone Metab"}, "ArticleTitle": "Exploring the Interplay between Vitamin D, Insulin Resistance, Obesity and Skeletal Health.", "Pagination": {"StartPage": "75", "EndPage": "89", "MedlinePgn": "75-89"}, "Abstract": {"AbstractText": ["Vitamin D (ViD), plays an important role in calcium absorption and bone mineralization, is associated with bone mineral density. Severe deficiency in ViD has long been linked to conditions such as rickets in children and osteomalacia in adults, revealing its substantial role in skeletal health. Additionally, investigations show an existing interconnection between ViD and insulin resistance (Ins-R), especially in patients with type 2 diabetes mellitus (T2DM). Obesity, in conjunction with Ins-R, may augment the risk of osteoporosis and deterioration of skeletal health. This review aims to examine recent studies on the interplay between ViD, Ins-R, obesity, and their impact on skeletal health, to offer insights into potential therapeutic strategies. Cochrane Library, Google Scholar, and Pubmed were searched to investigate relevant studies until December 2023. Current research demonstrates ViD's impact on pancreatic \u03b2-cell function, systemic inflammation, and insulin action regulation. Our findings highlight an intricate association between ViD, Ins-R, obesity, and skeletal health, providing a perspective for the prevention and/or treatment of skeletal disorders in patients with obesity, Ins-R, and T2DM."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, College of Pharmacy, University of Mosul, Mosul, Iraq."}], "LastName": "Abed", "ForeName": "Mohammed N", "Initials": "MN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, College of Pharmacy, University of Mosul, Mosul, Iraq."}], "LastName": "Alassaf", "ForeName": "Fawaz A", "Initials": "FA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy and Medicinal Plants, College of Pharmacy, University of Mosul, Mosul, Iraq."}], "LastName": "Qazzaz", "ForeName": "Mohannad E", "Initials": "ME"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Korea (South)", "MedlineTA": "J Bone Metab", "NlmUniqueID": "101599927", "ISSNLinking": "2287-6375"}, "CoiStatement": "\n<b>Conflict of interest</b>\n. No potential conflict of interest relevant to this article was reported."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Sheng B, Li X, Nussler AK, et al. The relationship between healthy lifestyles and bone health: a narrative review. Medicine (Baltimore) 2021;100:e24684. doi: 10.1097/md.0000000000024684.", "ArticleIdList": ["10.1097/md.0000000000024684", "PMC7909112", "33663079"]}, {"Citation": "Yee MMF, Chin KY, Ima-Nirwana S, et al. Vitamin a and bone health: a review on current evidence. Molecules. 2021;26:1757. doi: 10.3390/molecules26061757.", "ArticleIdList": ["10.3390/molecules26061757", "PMC8003866", "33801011"]}, {"Citation": "Campillo-S\u00e1nchez F, Usategui-Mart\u00edn R, Ruiz-de Temi\u00f1o \u00c1, et al. Relationship between insulin resistance (HOMA-IR), trabecular bone score (TBS), and three-dimensional dual-energy X-ray absorptiometry (3D-DXA) in non-diabetic postmenopausal women. J Clin Med. 2020;9:1732. doi: 10.3390/jcm9061732.", "ArticleIdList": ["10.3390/jcm9061732", "PMC7355807", "32503328"]}, {"Citation": "Alassaf FA, Jasim MHM, Alfahad M, et al. Effects of bee propolis on FBG, HbA1c, and insulin resistance in healthy volunteers. Turk J Pharm Sci. 2021;18:405\u20139. doi: 10.4274/tjps.galenos.2020.50024.", "ArticleIdList": ["10.4274/tjps.galenos.2020.50024", "PMC8430402", "34496480"]}, {"Citation": "Hofbauer LC, Busse B, Eastell R, et al. Bone fragility in diabetes: novel concepts and clinical implications. Lancet Diabetes Endocrinol. 2022;10:207\u201320. doi: 10.1016/s2213-8587(21)00347-8.", "ArticleIdList": ["10.1016/s2213-8587(21)00347-8", "35101185"]}, {"Citation": "Asokan AG, Jaganathan J, Philip R, et al. Evaluation of bone mineral density among type 2 diabetes mellitus patients in South Karnataka. J Nat Sci Biol Med. 2017;8:94\u20138. doi: 10.4103/0976-9668.198363.", "ArticleIdList": ["10.4103/0976-9668.198363", "PMC5320831", "28250682"]}, {"Citation": "Ahmed GM, Abed MN, Alassaf FA. The diabetic-anemia nexus: implications for clinical practice. Mil Med Sci Lett. 2023;92:1\u201311. doi: 10.31482/mmsl.2023.042.", "ArticleIdList": ["10.31482/mmsl.2023.042"]}, {"Citation": "Qatanani M, Lazar MA. Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev. 2007;21:1443\u201355. doi: 10.1101/gad.1550907.", "ArticleIdList": ["10.1101/gad.1550907", "17575046"]}, {"Citation": "Hadid kA, Alassaf FA, Abed MN. Mechanisms and linkage of insulin signaling, resistance, and inflammation. Iraqi J Pharm. 2024;21:1\u20138. doi: 10.33899/iphr.2023.144181.1065.", "ArticleIdList": ["10.33899/iphr.2023.144181.1065"]}, {"Citation": "Hou J, He C, He W, et al. Obesity and bone health: a complex link. Front Cell Dev Biol. 2020;8:600181. doi: 10.3389/fcell.2020.600181.", "ArticleIdList": ["10.3389/fcell.2020.600181", "PMC7779553", "33409277"]}, {"Citation": "Wondmkun YT. Obesity, insulin resistance, and type 2 diabetes: associations and therapeutic implications. Diabetes Metab Syndr Obes. 2020;13:3611\u20136. doi: 10.2147/dmso.S275898.", "ArticleIdList": ["10.2147/dmso.S275898", "PMC7553667", "33116712"]}, {"Citation": "Imerb N, Thonusin C, Chattipakorn N, et al. Aging, obese-insulin resistance, and bone remodeling. Mech Ageing Dev. 2020;191:111335. doi: 10.1016/j.mad.2020.111335.", "ArticleIdList": ["10.1016/j.mad.2020.111335", "32858037"]}, {"Citation": "Mohamed SM, Shalaby MA, El-Shiekh RA, et al. Metabolic syndrome: risk factors, diagnosis, pathogenesis, and management with natural approaches. Food Chem Adv. 2023;3:100335. doi: 10.1016/j.focha.2023.100335.", "ArticleIdList": ["10.1016/j.focha.2023.100335"]}, {"Citation": "C\u00e2ndido FG, Bressan J. Vitamin D: link between osteoporosis, obesity, and diabetes? Int J Mol Sci. 2014;15:6569\u201391. doi: 10.3390/ijms15046569.", "ArticleIdList": ["10.3390/ijms15046569", "PMC4013648", "24747593"]}, {"Citation": "Alnori H, Alassaf FA, Alfahad M, et al. Vitamin D and immunoglobulin E status in allergic rhinitis patients compared to healthy people. J Med Life. 2020;13:463\u20138. doi: 10.25122/jml-2020-0015.", "ArticleIdList": ["10.25122/jml-2020-0015", "PMC7803312", "33456593"]}, {"Citation": "Alassaf FA, Alfahad M, Jasim MHM, et al. Insights into the perspective correlation between vitamin D and regulation of hormones: adrenal hormones and vasopressin. Lat Am J Pharm. 2022;41:2242\u20137."}, {"Citation": "Alassaf FA, Qazzaz ME, Alfahad M, et al. Effects of bee propolis on thyroid function tests in healthy volunteers. Trop J Pharm Res. 2021;20:859\u201363. doi: 10.4314/tjpr.v20i4.28.", "ArticleIdList": ["10.4314/tjpr.v20i4.28", "PMC8430402", "34496480"]}, {"Citation": "Qazzaz ME, Abed MN, Alassaf FA, et al. Insights into the perspective correlation between vitamin D and regulation of hormones: sex hormones and prolactin. Curr Issues Pharm Med Sci. 2021;34:192\u2013200. doi: 10.2478/cipms-2021-0035.", "ArticleIdList": ["10.2478/cipms-2021-0035"]}, {"Citation": "Qazzaz ME, Alfahad M, Alassaf FA, et al. Effects of omega-3 on thyroid function tests in healthy volunteers. Syst Rev Pharm. 2020;11:10\u20134. doi: 10.31838/srp.2020.7.03.", "ArticleIdList": ["10.31838/srp.2020.7.03"]}, {"Citation": "Abed MN, Alassaf FA, Qazzaz ME, et al. Insights into the perspective correlation between vitamin D and regulation of hormones: thyroid and parathyroid hormones. Clin Rev Bone Miner Metab. 2020;18:87\u201393. doi: 10.1007/s12018-021-09279-6.", "ArticleIdList": ["10.1007/s12018-021-09279-6"]}, {"Citation": "Santos LRd, Lima AGA, Braz AF, et al. Role of vitamin D in insulin resistance in obese individuals. Nutrire. 2017;42:2\u20136."}, {"Citation": "Ahmed GM, Abed MN, Alassaf FA. An overview of the effects of sodium-glucose co-transporter-2 inhibitors on hematological parameters in diabetic patients. Iraqi J Pharm. 2023;20:65\u201371. doi: 10.33899/iphr.2023.137946.1041.", "ArticleIdList": ["10.33899/iphr.2023.137946.1041"]}, {"Citation": "Ahmed GM, Abed MN, Alassaf FA. Impact of calcium channel blockers and angiotensin receptor blockers on hematological parameters in type 2 diabetic patients. Naunyn Schmiedebergs Arch Pharmacol. 2024;397:1817\u201328. doi: 10.1007/s00210-023-02731-y.", "ArticleIdList": ["10.1007/s00210-023-02731-y", "37750935"]}, {"Citation": "Lopez N, Cohen SM, Emanuele M. Type 2 diabetes and bone disease. Clin Rev Bone Miner Metab. 2023;21:21\u201331. doi: 10.1007/s12018-023-09288-7.", "ArticleIdList": ["10.1007/s12018-023-09288-7"]}, {"Citation": "Cavati G, Pirrotta F, Merlotti D, et al. Role of advanced glycation end-products and oxidative stress in type-2-diabetes-induced bone fragility and implications on fracture risk stratification. Antioxidants (Basel) 2023;12:928. doi: 10.3390/antiox12040928.", "ArticleIdList": ["10.3390/antiox12040928", "PMC10135862", "37107303"]}, {"Citation": "Napoli N, Chandran M, Pierroz DD, et al. Mechanisms of diabetes mellitus-induced bone fragility. Nat Rev Endocrinol. 2017;13:208\u201319. doi: 10.1038/nrendo.2016.153.", "ArticleIdList": ["10.1038/nrendo.2016.153", "27658727"]}, {"Citation": "Cifuentes-Mendiola SE, Solis-Suarez DL, Mart\u00ednez-D\u00e1valos A, et al. CD4(+) T-cell activation of bone marrow causes bone fragility and insulin resistance in type 2 diabetes. Bone. 2022;155:116292. doi: 10.1016/j.bone.2021.116292.", "ArticleIdList": ["10.1016/j.bone.2021.116292", "34896656"]}, {"Citation": "Wei J, Ferron M, Clarke CJ, et al. Bone-specific insulin resistance disrupts whole-body glucose homeostasis via decreased osteocalcin activation. J Clin Invest. 2014;124:1\u201313. doi: 10.1172/jci72323.", "ArticleIdList": ["10.1172/jci72323", "PMC3973090", "24642469"]}, {"Citation": "Bradley D. The intriguing intersection of type 2 diabetes, obesity-related insulin resistance, and osteoarthritis. J Clin Endocrinol Metab. 2021;106:e2370\u2013e2. doi: 10.1210/clinem/dgab009.", "ArticleIdList": ["10.1210/clinem/dgab009", "PMC8063230", "33511986"]}, {"Citation": "Fu YH, Liu WJ, Lee CL, et al. Associations of insulin resistance and insulin secretion with bone mineral density and osteoporosis in a general population. Front Endocrinol (Lausanne) 2022;13:971960. doi: 10.3389/fendo.2022.971960.", "ArticleIdList": ["10.3389/fendo.2022.971960", "PMC9530363", "36204101"]}, {"Citation": "Guo H, Wang C, Jiang B, et al. Association of insulin resistance and \u03b2-cell function with bone turnover biomarkers in dysglycemia patients. Front Endocrinol (Lausanne) 2021;12:554604. doi: 10.3389/fendo.2021.554604.", "ArticleIdList": ["10.3389/fendo.2021.554604", "PMC8027237", "33841321"]}, {"Citation": "Wang X, Jiang L, Shao X. Association analysis of insulin resistance and osteoporosis risk in Chinese patients with T2DM. Ther Clin Risk Manag. 2021;17:909\u201316. doi: 10.2147/tcrm.S328510.", "ArticleIdList": ["10.2147/tcrm.S328510", "PMC8418372", "34511917"]}, {"Citation": "Napoli N, Conte C, Pedone C, et al. Effect of insulin resistance on BMD and fracture risk in older adults. J Clin Endocrinol Metab. 2019;104:3303\u201310. doi: 10.1210/jc.2018-02539.", "ArticleIdList": ["10.1210/jc.2018-02539", "PMC6584125", "30802282"]}, {"Citation": "Lei WS, Kindler JM. Insulin resistance and skeletal health. Curr Opin Endocrinol Diabetes Obes. 2022;29:343\u20139. doi: 10.1097/med.0000000000000738.", "ArticleIdList": ["10.1097/med.0000000000000738", "35749301"]}, {"Citation": "Rikkonen T, Sund R, Sirola J, et al. Obesity is associated with early hip fracture risk in postmenopausal women: a 25-year follow-up. Osteoporos Int. 2021;32:769\u201377. doi: 10.1007/s00198-020-05665-w.", "ArticleIdList": ["10.1007/s00198-020-05665-w", "PMC8026440", "33095419"]}, {"Citation": "Pi\u00f1ar-Gutierrez A, Garc\u00eda-Fontana C, Garc\u00eda-Fontana B, et al. Obesity and bone health: a complex relationship. Int J Mol Sci. 2022;23:8303. doi: 10.3390/ijms23158303.", "ArticleIdList": ["10.3390/ijms23158303", "PMC9368241", "35955431"]}, {"Citation": "Forte YS, Renovato-Martins M, Barja-Fidalgo C. Cellular and molecular mechanisms associating obesity to bone loss. Cells. 2023;12:521. doi: 10.3390/cells12040521.", "ArticleIdList": ["10.3390/cells12040521", "PMC9954309", "36831188"]}, {"Citation": "Jensen VFH, M\u00f8lck AM, Dalgaard M, et al. Changes in bone mass associated with obesity and weight loss in humans: applicability of animal models. Bone. 2021;145:115781. doi: 10.1016/j.bone.2020.115781.", "ArticleIdList": ["10.1016/j.bone.2020.115781", "33285255"]}, {"Citation": "Wu SF, Du XJ. Body mass index may positively correlate with bone mineral density of lumbar vertebra and femoral neck in postmenopausal females. Med Sci Monit. 2016;22:145\u201351. doi: 10.12659/msm.895512.", "ArticleIdList": ["10.12659/msm.895512", "PMC4716713", "26766815"]}, {"Citation": "Tang Y, Gong L, Chen X, et al. Age-related changes in body composition and bone mineral density and their relationship with the duration of diabetes and glycaemic control in type 2 diabetes. Diabetes Metab Syndr Obes. 2020;13:4699\u2013710. doi: 10.2147/dmso.S278425.", "ArticleIdList": ["10.2147/dmso.S278425", "PMC7719045", "33293843"]}, {"Citation": "Savvidis C, Tournis S, Dede AD. Obesity and bone metabolism. Hormones (Athens) 2018;17:205\u201317. doi: 10.1007/s42000-018-0018-4.", "ArticleIdList": ["10.1007/s42000-018-0018-4", "29858847"]}, {"Citation": "Palermo A, Tuccinardi D, Defeudis G, et al. BMI and BMD: the potential interplay between obesity and bone fragility. Int J Environ Res Public Health. 2016;13:544. doi: 10.3390/ijerph13060544.", "ArticleIdList": ["10.3390/ijerph13060544", "PMC4924001", "27240395"]}, {"Citation": "Asli IN, Sheikhnezami M, Qutbi M, et al. Less influence of body mass index on bone mineral density of radius as compared to proximal femur: possible role in the diagnosis of osteoporosis. World J Nucl Med. 2020;19:118\u201323. doi: 10.4103/wjnm.WJNM_39_19.", "ArticleIdList": ["10.4103/wjnm.WJNM_39_19", "PMC7478315", "32939198"]}, {"Citation": "Rolvien T, Amling M. Disuse osteoporosis: clinical and mechanistic insights. Calcif Tissue Int. 2022;110:592\u2013604. doi: 10.1007/s00223-021-00836-1.", "ArticleIdList": ["10.1007/s00223-021-00836-1", "PMC9013332", "33738515"]}, {"Citation": "Singhal V, Huynh C, Nimmala S, et al. Load-to-strength ratio at the radius is higher in adolescent and young adult females with obesity compared to normal-weight controls. Bone. 2022;164:116515. doi: 10.1016/j.bone.2022.116515.", "ArticleIdList": ["10.1016/j.bone.2022.116515", "PMC9826712", "35948256"]}, {"Citation": "Shapses SA, Pop LC, Wang Y. Obesity is a concern for bone health with aging. Nutr Res. 2017;39:1\u201313. doi: 10.1016/j.nutres.2016.12.010.", "ArticleIdList": ["10.1016/j.nutres.2016.12.010", "PMC5385856", "28385284"]}, {"Citation": "Turcotte AF, O,Connor S, Morin SN, et al. Association between obesity and risk of fracture, bone mineral density and bone quality in adults: a systematic review and meta-analysis. PLoS One. 2021;16:e0252487. doi: 10.1371/journal.pone.0252487.", "ArticleIdList": ["10.1371/journal.pone.0252487", "PMC8186797", "34101735"]}, {"Citation": "Marcus C, Danielsson P, Hagman E. Pediatric obesity-Long-term consequences and effect of weight loss. J Intern Med. 2022;292:870\u201391. doi: 10.1111/joim.13547.", "ArticleIdList": ["10.1111/joim.13547", "PMC9805112", "35883220"]}, {"Citation": "Yamamoto A, Kikuchi Y, Kusakabe T, et al. Imaging spectrum of abnormal subcutaneous and visceral fat distribution. Insights Imaging. 2020;11:24. doi: 10.1186/s13244-019-0833-4.", "ArticleIdList": ["10.1186/s13244-019-0833-4", "PMC7018866", "32056035"]}, {"Citation": "Mendon\u00e7a FM, Soares R, Carvalho D, et al. The impact of obesity on bone health: an overview. Endokrynol Pol. 2022;73:954\u20138. doi: 10.5603/EP.a2022.0063.", "ArticleIdList": ["10.5603/EP.a2022.0063", "36519653"]}, {"Citation": "Korac A, Srdic-Galic B, Kalezic A, et al. Adipokine signatures of subcutaneous and visceral abdominal fat in normal-weight and obese women with different metabolic profiles. Arch Med Sci. 2021;17:323\u201336. doi: 10.5114/aoms/92118.", "ArticleIdList": ["10.5114/aoms/92118", "PMC7959090", "33747267"]}, {"Citation": "Moon HU, Ha KH, Han SJ, et al. The association of adiponectin and visceral fat with insulin resistance and \u03b2-Cell dysfunction. J Korean Med Sci. 2019;34:e7. doi: 10.3346/jkms.2019.34.e7.", "ArticleIdList": ["10.3346/jkms.2019.34.e7", "PMC6318440", "30618514"]}, {"Citation": "Gilsanz V, Chalfant J, Mo AO, et al. Reciprocal relations of subcutaneous and visceral fat to bone structure and strength. J Clin Endocrinol Metab. 2009;94:3387\u201393. doi: 10.1210/jc.2008-2422.", "ArticleIdList": ["10.1210/jc.2008-2422", "PMC2741723", "19531595"]}, {"Citation": "Laird E, Ward M, McSorley E, Strain JJ, et al. Vitamin D and bone health: potential mechanisms. Nutrients. 2010;2:693\u2013724. doi: 10.3390/nu2070693.", "ArticleIdList": ["10.3390/nu2070693", "PMC3257679", "22254049"]}, {"Citation": "Poiana C, Capatina C. Fracture risk assessment in patients with diabetes mellitus. J Clin Densitom. 2017;20:432\u201343. doi: 10.1016/j.jocd.2017.06.011.", "ArticleIdList": ["10.1016/j.jocd.2017.06.011", "28716499"]}, {"Citation": "Sung CC, Liao MT, Lu KC, et al. Role of vitamin D in insulin resistance. J Biomed Biotechnol. 2012;2012 doi: 10.1155/2012/634195. 634195.", "ArticleIdList": ["10.1155/2012/634195", "PMC3440067", "22988423"]}, {"Citation": "Farahmand MA, Daneshzad E, Fung TT, et al. What is the impact of vitamin D supplementation on glycemic control in people with type-2 diabetes: a systematic review and meta-analysis of randomized controlled trails. BMC Endocr Disord. 2023;23:15. doi: 10.1186/s12902-022-01209-x.", "ArticleIdList": ["10.1186/s12902-022-01209-x", "PMC9841647", "36647067"]}, {"Citation": "Szymczak-Pajor I, Drzewoski J, \u015aliwi\u0144ska A. The molecular mechanisms by which vitamin D prevents insulin resistance and associated disorders. Int J Mol Sci. 2020;21:6644. doi: 10.3390/ijms21186644.", "ArticleIdList": ["10.3390/ijms21186644", "PMC7554927", "32932777"]}, {"Citation": "Hu Z, Chen J, Sun X, et al. Efficacy of vitamin D supplementation on glycemic control in type 2 diabetes patients: a meta-analysis of interventional studies. Medicine (Baltimore) 2019;98:e14970. doi: 10.1097/md.0000000000014970.", "ArticleIdList": ["10.1097/md.0000000000014970", "PMC6456062", "30946322"]}, {"Citation": "Khan Z, Muhammad SA, Carpio J, et al. The effect of vitamin D supplementation on incidence of type 2 diabetes: a systematic review. Cureus. 2023;15:e36775. doi: 10.7759/cureus.36775.", "ArticleIdList": ["10.7759/cureus.36775", "PMC10133782", "37123701"]}, {"Citation": "Mohd Ghozali N, Giribabu N, Salleh N. Mechanisms linking vitamin D deficiency to impaired metabolism: an overview. Int J Endocrinol. 2022;2022 doi: 10.1155/2022/6453882. 6453882.", "ArticleIdList": ["10.1155/2022/6453882", "PMC9293580", "35859985"]}, {"Citation": "Kjalarsdottir L, Tersey SA, Vishwanath M, et al. 1,25-Dihydroxyvitamin D(3) enhances glucose-stimulated insulin secretion in mouse and human islets: a role for transcriptional regulation of voltage-gated calcium channels by the vitamin D receptor. J Steroid Biochem Mol Biol. 2019;185:17\u201326. doi: 10.1016/j.jsbmb.2018.07.004.", "ArticleIdList": ["10.1016/j.jsbmb.2018.07.004", "30071248"]}, {"Citation": "Hoseini SA, Aminorroaya A, Iraj B, et al. The effects of oral vitamin D on insulin resistance in pre-diabetic patients. J Res Med Sci. 2013;18:47\u201351.", "ArticleIdList": ["PMC3719226", "23900423"]}, {"Citation": "Rohm TV, Meier DT, Olefsky JM, et al. Inflammation in obesity, diabetes, and related disorders. Immunity. 2022;55:31\u201355. doi: 10.1016/j.immuni.2021.12.013.", "ArticleIdList": ["10.1016/j.immuni.2021.12.013", "PMC8773457", "35021057"]}, {"Citation": "Lempesis IG, Georgakopoulou VE. Physiopathological mechanisms related to inflammation in obesity and type 2 diabetes mellitus. World J Exp Med. 2023;13:7\u201316. doi: 10.5493/wjem.v13.i3.7.", "ArticleIdList": ["10.5493/wjem.v13.i3.7", "PMC10308320", "37396883"]}, {"Citation": "Gkastaris K, Goulis DG, Potoupnis M, et al. Obesity, osteoporosis and bone metabolism. J Musculoskelet Neuronal Interact. 2020;20:372\u201381.", "ArticleIdList": ["PMC7493444", "32877973"]}, {"Citation": "Rafiq S, Jeppesen PB. Body mass index, vitamin D, and type 2 diabetes: a systematic review and meta-analysis. Nutrients. 2018;10:1182. doi: 10.3390/nu10091182.", "ArticleIdList": ["10.3390/nu10091182", "PMC6164132", "30154381"]}, {"Citation": "Vrani\u0107 L, Mikola\u0161evi\u0107 I, Mili\u0107 S. Vitamin D deficiency: consequence or cause of obesity? Medicina (Kaunas) 2019;55:541. doi: 10.3390/medicina55090541.", "ArticleIdList": ["10.3390/medicina55090541", "PMC6780345", "31466220"]}, {"Citation": "Masenga SK, Kabwe LS, Chakulya M, et al. Mechanisms of oxidative stress in metabolic syndrome. Int J Mol Sci. 2023;24:7898. doi: 10.3390/ijms24097898.", "ArticleIdList": ["10.3390/ijms24097898", "PMC10178199", "37175603"]}, {"Citation": "Abed MN, Alassaf FA, Jasim MHM, et al. Comparison of antioxidant effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole. Pharmacology. 2020;105:645\u201351. doi: 10.1159/000506232.", "ArticleIdList": ["10.1159/000506232", "32289807"]}, {"Citation": "Alfahad M, Qazzaz ME, Abed MN, et al. Comparison of anti-oxidant activity of different brands of esomeprazole available in Iraqi pharmacies. Syst Rev Pharm. 2020;11:330\u20134. doi: 10.31838/srp.2020.5.48.", "ArticleIdList": ["10.31838/srp.2020.5.48"]}, {"Citation": "Biswas L, Niveria K, Verma AK. Paradoxical role of reactive oxygen species in bone remodelling: implications in osteoporosis and possible nanotherapeutic interventions. Explor Med. 2022;3:393\u2013413. doi: 10.37349/emed.2022.00102.", "ArticleIdList": ["10.37349/emed.2022.00102"]}, {"Citation": "Queiroz DJM, Silva AS, Silva J\u00fanior CCD, et al. Vitamin D levels and their association with oxidative stress and inflammation markers in patients with cystic fibrosis. Nutr Hosp. 2023;40:280\u20135. doi: 10.20960/nh.04253.", "ArticleIdList": ["10.20960/nh.04253", "36719006"]}, {"Citation": "Wimalawansa SJ. Vitamin D deficiency: effects on oxidative stress, epigenetics, gene regulation, and aging. Biology (Basel) 2019;8:30. doi: 10.3390/biology8020030.", "ArticleIdList": ["10.3390/biology8020030", "PMC6627346", "31083546"]}, {"Citation": "Ibrahim SL, Abed MN, Mohamed G, et al. Inhibition of branched-chain alpha-keto acid dehydrogenase kinase augments the sensitivity of ovarian and breast cancer cells to paclitaxel. Br J Cancer. 2023;128:896\u2013906. doi: 10.1038/s41416-022-02095-9.", "ArticleIdList": ["10.1038/s41416-022-02095-9", "PMC9977917", "36526674"]}, {"Citation": "Ijeoma Uche F, Abed MN, Abdullah MI, et al. Isochondodendrine and 2-norcocsuline: additional alkaloids from triclisia subcordata induce cytotoxicity and apoptosis in ovarian cancer cell lines. RSC Adv. 2017;7:44154\u201361. doi: 10.1039/C7RA08032H.", "ArticleIdList": ["10.1039/C7RA08032H"]}, {"Citation": "Alnaser RI, Alassaf F, Abed MN. Adulteration of hypoglycemic products: the silent threat. Rom J Med Pract. 2023;18:157\u201360. doi: 10.37897/RJMP.2023.4.4.", "ArticleIdList": ["10.37897/RJMP.2023.4.4"]}, {"Citation": "Majumdar SR, Leslie WD, Lix LM, et al. Longer duration of diabetes strongly impacts fracture risk assessment: the manitoba BMD cohort. J Clin Endocrinol Metab. 2016;101:4489\u201396. doi: 10.1210/jc.2016-2569.", "ArticleIdList": ["10.1210/jc.2016-2569", "PMC5095256", "27603908"]}, {"Citation": "Oei L, Zillikens MC, Dehghan A, et al. High bone mineral density and fracture risk in type 2 diabetes as skeletal complications of inadequate glucose control: the Rotterdam Study. Diabetes Care. 2013;36:1619\u201328. doi: 10.2337/dc12-1188.", "ArticleIdList": ["10.2337/dc12-1188", "PMC3661786", "23315602"]}, {"Citation": "Pittas AG, Jorde R, Kawahara T, et al. Vitamin D supplementation for prevention of type 2 diabetes mellitus: to D or not to D? J Clin Endocrinol Metab. 2020;105:3721\u201333. doi: 10.1210/clinem/dgaa594.", "ArticleIdList": ["10.1210/clinem/dgaa594", "PMC7571449", "32844212"]}, {"Citation": "Charoenngam N, Shirvani A, Holick MF. Vitamin D for skeletal and non-skeletal health: what we should know. J Clin Orthop Trauma. 2019;10:1082\u201393. doi: 10.1016/j.jcot.2019.07.004.", "ArticleIdList": ["10.1016/j.jcot.2019.07.004", "PMC6834997", "31708633"]}, {"Citation": "Krisnamurti DGB, Louisa M, Poerwaningsih EH, et al. Vitamin D supplementation alleviates insulin resistance in prediabetic rats by modifying IRS-1 and PPAR\u03b3/NF-\u03baB expressions. Front Endocrinol (Lausanne) 2023;14:1089298. doi: 10.3389/fendo.2023.1089298.", "ArticleIdList": ["10.3389/fendo.2023.1089298", "PMC10266204", "37324274"]}, {"Citation": "Sun LJ, Lu JX, Li XY, et al. Effects of vitamin D supplementation on glucose and lipid metabolism in patients with type 2 diabetes mellitus and risk factors for insulin resistance. World J Diabetes. 2023;14:1514\u201323. doi: 10.4239/wjd.v14.i10.1514.", "ArticleIdList": ["10.4239/wjd.v14.i10.1514", "PMC10642416", "37970127"]}, {"Citation": "Walsh JS, Evans AL, Bowles S, et al. Free 25-hydroxyvitamin D is low in obesity, but there are no adverse associations with bone health. Am J Clin Nutr. 2016;103:1465\u201371. doi: 10.3945/ajcn.115.120139.", "ArticleIdList": ["10.3945/ajcn.115.120139", "27169839"]}, {"Citation": "Athanassiou L, Mavragani CP, Koutsilieris M. The immunomodulatory properties of vitamin D. Mediterr J Rheumatol. 2022;33:7\u201313. doi: 10.31138/mjr.33.1.7.", "ArticleIdList": ["10.31138/mjr.33.1.7", "PMC9092099", "35611096"]}, {"Citation": "Pereda CA, Nishishinya MB. Optimal dosage of vitamin D supplementation in obese patients with low serum levels of 25-Hydroxyvitamin D: a systematic review. Obes Med. 2022;29:100381. doi: 10.1016/j.obmed.2021.100381.", "ArticleIdList": ["10.1016/j.obmed.2021.100381"]}, {"Citation": "Della Nera G, Sabatino L, Gaggini M, et al. Vitamin D determinants, status, and antioxidant/anti-inflammatory-related effects in cardiovascular risk and disease: not the last word in the controversy. Antioxidants (Basel) 2023;12:948. doi: 10.3390/antiox12040948.", "ArticleIdList": ["10.3390/antiox12040948", "PMC10135791", "37107323"]}, {"Citation": "Matta Reddy A, Iqbal M, Chopra H, et al. Pivotal role of vitamin D in mitochondrial health, cardiac function, and human reproduction. Excli j. 2022;21:967\u201390. doi: 10.17179/excli2022-4935.", "ArticleIdList": ["10.17179/excli2022-4935", "PMC9441677", "36110560"]}, {"Citation": "Eller-Vainicher C, Cairoli E, Grassi G, et al. Pathophysiology and management of type 2 diabetes mellitus bone fragility. J Diabetes Res. 2020;2020 doi: 10.1155/2020/7608964. 7608964.", "ArticleIdList": ["10.1155/2020/7608964", "PMC7262667", "32566682"]}, {"Citation": "Loh DKW, Kadirvelu A, Pamidi N. Effects of metformin on bone mineral density and adiposity-associated pathways in animal models with type 2 diabetes mellitus: a systematic review. J Clin Med. 2022;11:4193. doi: 10.3390/jcm11144193.", "ArticleIdList": ["10.3390/jcm11144193", "PMC9323116", "35887957"]}, {"Citation": "Wang LX, Wang GY, Su N, et al. Effects of different doses of metformin on bone mineral density and bone metabolism in elderly male patients with type 2 diabetes mellitus. World J Clin Cases. 2020;8:4010\u20136. doi: 10.12998/wjcc.v8.i18.4010.", "ArticleIdList": ["10.12998/wjcc.v8.i18.4010", "PMC7520776", "33024757"]}, {"Citation": "Zhang YW, Lu PP, Li YJ, et al. Prevalence, characteristics, and associated risk factors of the elderly with hip fractures: a cross-sectional analysis of NHANES 2005\u20132010. Clin Interv Aging. 2021;16:177\u201385. doi: 10.2147/cia.S291071.", "ArticleIdList": ["10.2147/cia.S291071", "PMC7851483", "33542622"]}, {"Citation": "Zhang Z, Cao Y, Tao Y, et al. Sulfonylurea and fracture risk in patients with type 2 diabetes mellitus: a meta-analysis. Diabetes Res Clin Pract. 2020;159:107990. doi: 10.1016/j.diabres.2019.107990.", "ArticleIdList": ["10.1016/j.diabres.2019.107990", "31866530"]}, {"Citation": "Ma P, Gu B, Xiong W, et al. Glimepiride promotes osteogenic differentiation in rat osteoblasts via the PI3K/Akt/eNOS pathway in a high glucose microenvironment. PLoS One. 2014;9:e112243. doi: 10.1371/journal.pone.0112243.", "ArticleIdList": ["10.1371/journal.pone.0112243", "PMC4229122", "25391146"]}, {"Citation": "Alkharfy KM, Al-Daghri NM, Sabico SB, et al. Vitamin D supplementation in patients with diabetes mellitus type 2 on different therapeutic regimens: a one-year prospective study. Cardiovasc Diabetol. 2013;12:113. doi: 10.1186/1475-2840-12-113.", "ArticleIdList": ["10.1186/1475-2840-12-113", "PMC3750473", "23924389"]}, {"Citation": "Falchetti A, Masi L, Brandia ML. Thiazolidinediones and bone. Clin Cases Miner Bone Metab. 2007;4:103\u20137.", "ArticleIdList": ["PMC2781240", "22461209"]}, {"Citation": "Zhao C, Liang J, Yang Y, et al. The impact of glucagon-like peptide-1 on bone metabolism and its possible mechanisms. Front Endocrinol (Lausanne) 2017;8:98. doi: 10.3389/fendo.2017.00098.", "ArticleIdList": ["10.3389/fendo.2017.00098", "PMC5413504", "28515711"]}, {"Citation": "Xie B, Chen S, Xu Y, et al. The impact of glucagon-like peptide 1 receptor agonists on bone metabolism and its possible mechanisms in osteoporosis treatment. Front Pharmacol. 2021;12:697442. doi: 10.3389/fphar.2021.697442.", "ArticleIdList": ["10.3389/fphar.2021.697442", "PMC8243369", "34220521"]}, {"Citation": "Daniilopoulou I, Vlachou E, Lambrou GI, et al. The impact of GLP1 agonists on bone metabolism: a systematic review. Medicina (Kaunas) 2022;58:224. doi: 10.3390/medicina58020224.", "ArticleIdList": ["10.3390/medicina58020224", "PMC8878541", "35208548"]}, {"Citation": "Huang L, Zhong W, Liang X, et al. Meta-analysis on the association between DPP-4 inhibitors and bone mineral density and osteoporosis. J Clin Densitom. 2024;27:101455. doi: 10.1016/j.jocd.2023.101455.", "ArticleIdList": ["10.1016/j.jocd.2023.101455", "38101289"]}, {"Citation": "Yang Y, Zhao C, Liang J, et al. Effect of dipeptidyl peptidase-4 inhibitors on bone metabolism and the possible underlying mechanisms. Front Pharmacol. 2017;8:487. doi: 10.3389/fphar.2017.00487.", "ArticleIdList": ["10.3389/fphar.2017.00487", "PMC5524773", "28790917"]}, {"Citation": "Zhuo M, Hawley CE, Paik JM, et al. Association of sodium-glucose cotransporter-2 inhibitors with fracture risk in older adults with type 2 diabetes. JAMA Netw Open. 2021;4:e2130762. doi: 10.1001/jamanetworkopen.2021.30762.", "ArticleIdList": ["10.1001/jamanetworkopen.2021.30762", "PMC8552056", "34705014"]}, {"Citation": "Al-Mashhadi ZK, Viggers R, Starup-Linde J, et al. SGLT2 inhibitor treatment is not associated with an increased risk of osteoporotic fractures when compared to GLP-1 receptor agonists: a nationwide cohort study. Front Endocrinol (Lausanne) 2022;13:861422. doi: 10.3389/fendo.2022.861422.", "ArticleIdList": ["10.3389/fendo.2022.861422", "PMC9437938", "36060970"]}, {"Citation": "Blau JE, Bauman V, Conway EM, et al. Canagliflozin triggers the FGF23/1,25-dihydroxyvitamin D/PTH axis in healthy volunteers in a randomized crossover study. JCI Insight. 2018;3:e99123. doi: 10.1172/jci.insight.99123.", "ArticleIdList": ["10.1172/jci.insight.99123", "PMC5931122", "29669938"]}, {"Citation": "Hidayat K, Fang QL, Shi BM, et al. Influence of glycemic control and hypoglycemia on the risk of fracture in patients with diabetes mellitus: a systematic review and meta-analysis of observational studies. Osteoporos Int. 2021;32:1693\u2013704. doi: 10.1007/s00198-021-05934-2.", "ArticleIdList": ["10.1007/s00198-021-05934-2", "33860816"]}, {"Citation": "Wang B, Wang Z, Poundarik AA, et al. Unmasking fracture risk in type 2 diabetes: the association of longitudinal glycemic hemoglobin level and medications. J Clin Endocrinol Metab. 2022;107:e1390\u2013e401. doi: 10.1210/clinem/dgab882.", "ArticleIdList": ["10.1210/clinem/dgab882", "PMC8947783", "34888676"]}, {"Citation": "American Diabetes Association Professional Practice Committee 4. Comprehensive medical evaluation and assessment of comorbidities: standards of care in diabetes-2024. Diabetes Care. 2024;47:S52\u2013S76. doi: 10.2337/dc24-S004.", "ArticleIdList": ["10.2337/dc24-S004", "PMC10725809", "38078591"]}, {"Citation": "Puar TH, Khoo JJ, Cho LW, et al. Association between glycemic control and hip fracture. J Am Geriatr Soc. 2012;60:1493\u20137. doi: 10.1111/j.1532-5415.2012.04052.x.", "ArticleIdList": ["10.1111/j.1532-5415.2012.04052.x", "22862735"]}, {"Citation": "Johnston SS, Conner C, Aagren M, et al. Association between hypoglycaemic events and fall-related fractures in Medicare-covered patients with type 2 diabetes. Diabetes Obes Metab. 2012;14:634\u201343. doi: 10.1111/j.1463-1326.2012.01583.x.", "ArticleIdList": ["10.1111/j.1463-1326.2012.01583.x", "22335246"]}]}], "History": [{"Year": "2023", "Month": "12", "Day": "15"}, {"Year": "2024", "Month": "2", "Day": "17"}, {"Year": "2024", "Month": "6", "Day": "18", "Hour": "6", "Minute": "42"}, {"Year": "2024", "Month": "6", "Day": "18", "Hour": "6", "Minute": "41"}, {"Year": "2024", "Month": "6", "Day": "18", "Hour": "0", "Minute": "49"}, {"Year": "2024", "Month": "5", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["38886966", "PMC11184154", "10.11005/jbm.2024.31.2.75", "jbm.2024.31.2.75"]}}]}